Clinical Trials Directory

Trials / Completed

CompletedNCT00593918

Innate Immunity and Respiratory Syncytial Virus (RSV) Infection in Children

Innate Immunity and RSV Infection in Children

Status
Completed
Phase
Study type
Observational
Enrollment
91 (actual)
Sponsor
University of Wisconsin, Madison · Academic / Other
Sex
All
Age
24 Months
Healthy volunteers
Accepted

Summary

In this project we will study the capacity for single nucleotide polymorphisms (SNP) in TLR4 gene to induce varying levels of inflammatory chemokine and cytokine production.

Detailed description

Infection with RSV is the most common cause of respiratory tract illnesses (LRIs) in the first 3 years of life. There are significant social and health care costs associated with RSV-LRIs. More than 3% of US children are hospitalized each year due to RSV and 500 die annually. Several longitudinal studies have also suggested that children who have RSV-LRIs are at substantially increased risk of developing asthma in the first 3 years after infection and bronchial hyperresponsiveness (BHR) many years after the primary infection. Mechanisms involved in RSV disease are not well understood. Recent reports suggest that RSV may initiate the innate immune response through the pattern recognition receptor, Toll like receptor-4 (TLR4). In this project we will study the capacity for single nucleotide polymorphisms (SNP) in TLR4 gene to induce varying levels of inflammatory chemokine and cytokine production. It has been suggested that such a mechanism may result in altered immune responses to RSV infection and different clinical outcomes. This research has direct application to improving our understanding of bronchiolitis in early childhood, particularly those factors that influence severity of the disease, and may have implications for possible therapy of patients with bronchiolitis in the future.

Conditions

Timeline

Start date
2003-11-01
Primary completion
2008-05-01
Completion
2008-06-01
First posted
2008-01-15
Last updated
2015-10-20
Results posted
2010-05-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00593918. Inclusion in this directory is not an endorsement.